371
Views
7
CrossRef citations to date
0
Altmetric
Review

Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy: current strategies

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yonghua Wang, Jing Liu, Xuecheng Yang, Yanan Liu, Yong Liu, Yanjiang Li, Lijiang Sun, Xiaokun Yang & Haitao Niu. (2018) Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer. OncoTargets and Therapy 11, pages 2891-2899.
Read now

Articles from other publishers (6)

Francesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, Luigi Maria Larocca, Pier Francesco Bassi, Riccardo Bientinesi, Gianna Baroni, Andrea Minervini, Guido Petracco, Giacomo Maria Pini & Carlo Patriarca. (2020) PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders. Virchows Archiv 477:2, pages 269-277.
Crossref
João Lobo, Carmen Jerónimo & Rui Henrique. (2020) Targeting the Immune system and Epigenetic Landscape of Urological Tumors. International Journal of Molecular Sciences 21:3, pages 829.
Crossref
Dunia Rodriguez, Cibelly Goulart, Ana C. Pagliarone, Eliane P. Silva, Priscila S. Cunegundes, Ivan P. Nascimento, Ricardo C. Borra, Waldely O. Dias, Aldo Tagliabue, Diana Boraschi & Luciana C. C. Leite. (2019) In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment. Frontiers in Immunology 10.
Crossref
Michael A. Morse. (2016) Immunotherapy for Resected Pulmonary Metastases. Thoracic Surgery Clinics 26:1, pages 69-78.
Crossref
Farhad Fakhrejahani, Yusuke Tomita, Agnes Maj-Hes, Jane B. Trepel, Maria De Santis & Andrea B. Apolo. (2015) Immunotherapies for bladder cancer. Current Opinion in Urology 25:6, pages 586-596.
Crossref
Sam J. BrancatoKeidren LewiPiyush K. Agarwal. (2015) Evolving Immunotherapy Strategies in Urothelial Cancer. American Society of Clinical Oncology Educational Book:35, pages e284-e290.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.